HBM Holdings Limited focuses on innovative therapies in the field of tumor immunology and immune diseases. The company's products are mainly used in immune thrombocytopenia, thyroid associated ophthalmopathy, myasthenia gravis, neuromyelitis optica spectrum diseases. The company was established in 2016 and headquartered in Shanghai City, China.
Headquarters
12Th Floor, Tower A, Fenglin International Plaza Phase Ii, 420 Fenglin Road, Xuhui District
Shanghai; Shanghai;
Contact Details: Purchase the HBM Holdings Limited report to view the information.
Website: http://www.harbourbiomed.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service